drugset / Trial / NCT00960856

Four Arm Food Effect Study of Fenofibric Acid Tablets

NCT00960856

Phase 1 Completed 40 enrolled Mutual Pharmaceutical Company, Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

The primary objective of this study is to characterize the single-dose pharmacokinetic profile of fenofibric acid (105 mg tablets) and the effect of food of various calorie/fat compositions on the rate and extent of absorption. Additionally, the safety and tolerability of this dose and regimen of fenofibric acid will be evaluated.

Timeline

Start
2007-11
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject fenofibric acid Small molecule 105 mg Oral

Indications

No indication recorded.